High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the City of Oslo, and its phenotypic expression

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 5, 1999, Pages 529-534

  Distante, Sonia ^a   Berg, J P ^a   Lande, K ^a   Haug, E ^a   Bell, H ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Ferritin; Hemochromatosis; HFE gene mutation; Inherited disorders; Iron; Transferrin saturation

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGED; ARTICLE; FEMALE; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; NORWAY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; FEMALE; FERRITINS; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; NORWAY; PREVALENCE; TRANSFERRIN;

EID: 0032986271     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655299750026290     Document Type: Article

References (28)

1. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355-62.
2. Niderau C, Fisher R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
3. Simon M, Bourel R, Fauchet R, Genetet B. Association of HLA-A3 and HLA-B14 antigens with idiopathic hemochromatosis. Gut 1976;17:332-4.
4. Raha-Chowdhury R, Bowen DJ, Stone C, Pointon JJ, Terwilliger JD, Shearman JD, et al. New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum Mol Genet 1995;4:1869-74.
5. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MCH class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 1996;13:399-408.
6. Lebron JI, Bennett MJ, Vaughn DA, Chirino AJ, Snow PM, Mintier GA, et al. Crystal structure of the hemochromatosis protein HFE and characterisation of its interaction with transferrin receptor. Cell 1998;93:111-23.
7. Siedel J, Wahlefeld AW, Ziegenhorn J. Improved ferrozine r-based reagent for the determination of serum iron (transferrin iron) without deproteinisation. AACC Meeting [abstract]. Clin Chem 1984;30:975.
8. Lievens M, Borque De Larrea L, Rus A, Cottenceau D, Ferrari L, Bassi et al. Determination of transferrin without sample predilution by a turbidimetric assay on Boehringer Mannheim/Hitachi analysis systems. Lab Med 1994;18:83-90.
9. Pei P, Neumaier I, Gloor R, Vonderschmitt DJ. Performance of the ACS: 180 for the determination of PSA, ferritin and thyroid function. Klin Lab 1993;39:551-2.
10. Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. J Hepatol 1986;6:24-9.
11. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
12. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996;22:187-94.
13. Barton JC, Shih WW, Sawada-Hirai R, Acton RT, Harmon L, Rivers C, et al. Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis. Blood Cells Mol Dis 1997;23:135-45.
14. Borot N, Roth MP, Malfroy L, Demangel C, Vinel JP, Pascal JP, et al. Mutation in MCH class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997;45:320-4.
15. UK Haemochromatosis Consortium. A simple genetic test identifies 90 percent of UK patients with haemochromatosis. Gut 1997;41:841-4.
16. Cardoso MP, Stǎl Å, Hagen K, Cabeda M, Esin S, De Sousa M, et al. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Int Med 1998;243:203-8.
17. Datz C, Lalloz M, Vogel W, Graziadei I, Hackl F, Vautier G. Predominance of the HLA-H Cys 282 Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol 1997;27:733-79.
18. Carella M, D'Ambrosiso L, Totaro A, Grifa A, Valentino MA, Piperno A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997;60:828-32.
19. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW. Haemochromatosis and HLA-H. Nature Genet 1996;14:149-51.
20. Jouanolle AM, Gandon G, Jezequel P, Blayau M, Campion ML, Yaouang Y, et al. Haemochromatosis and HLA-H. Nature Genet 1996;14:251-2.
21. Olsson KS, Heedman PA, Staugård F. Preclinical heamochromatosis in a population on a high iron fortified diet. JAMA 1978;239:1999-2000.
22. Olsson KS, Ritter B. Idiopatisk hemokromatose. Tidsskr Nor Laegeforen 1981;29:1664-4.
23. Olsson KS, Ritter B, Rosen U, Heedman PA, Staugård F. Prevalence of iron overload in central Sweden. Acta Med Scand 1983;213:145-50.
24. Ajioka RS, Jorde LB, Gruen JR, Yu P, Dimitrova D, Barrow J, et al. Haplotype analysis of hemochromatosis: evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes. Am J Hum Genet 1997;60:1439-47.
25. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 1996;335:1799-1805.
26. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC. Hereditary hemochromatosis: gene discovery and its implications for population screening. JAMA 1998;280:172-8.
27. Bell H, Thordal C, Raknerud N, Hansen T, Bosnes V, Halvorsen R, et al. Prevalence of hemochromatosis among first time and repeat blood donors in Norway. J Hepatol 1997;26:272-9.
28. Little P. Human genetics: woman's meat, a man's poison. Nature 1996;382:494-5.